Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 32, Issue 12, Pages 3058-3065
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-10-13
DOI
10.1161/atvbaha.112.255521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects
- (2012) Salvatore Santo Signorelli et al. CYTOKINE
- Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis
- (2012) et al. MEDICAL JOURNAL OF AUSTRALIA
- Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
- (2011) Adam Taleb et al. Biomarkers in Medicine
- Lipoprotein(a) Genetic Variants Associated With Coronary and Peripheral Vascular Disease but Not With Stroke Risk in the Heart Protection Study
- (2011) Jemma C. Hopewell et al. Circulation-Cardiovascular Genetics
- Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
- (2011) Yonghong Li et al. Circulation-Cardiovascular Genetics
- Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia
- (2011) Fatima Akdim et al. EUROPEAN HEART JOURNAL
- 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline)
- (2011) Thom W. Rooke et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
- (2010) Tracie A. Seimon et al. Cell Metabolism
- The Next 10 years in the Management of Peripheral Artery Disease: Perspectives from The ‘PAD 2009’ Conference
- (2010) L. Norgren et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events
- (2010) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Symptomatic Peripheral Arterial Disease in Women
- (2008) Aruna D. Pradhan et al. CIRCULATION
- The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans
- (2008) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started